{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:52:44Z","timestamp":1787503964146,"version":"build-2736575974"},"reference-count":111,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T00:00:00Z","timestamp":1221091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:p>\n                    <jats:bold>Abstract:\u2002<\/jats:bold>\n                    The C3H\/HeJ inbred mouse strain and the Dundee Experimental Bald Rat (DEBR) strain spontaneously develop adult onset alopecia areata (AA), a cell\u2010mediated disease directed against actively growing hair follicles. The low frequency of AA and the inability to predict the stage of AA as it evolves in the naturally occuring C3H\/HeJ model of AA can be converted into a highly predictable system by grafting full thickness skin from AA\u2010affected mice to normal haired mice of the same strain. The rat DEBR model develops spontaneous AA at a higher frequency than in the mouse model but they are more expensive to use in drug studies owing to their larger size. Regardless of the shortcomings of either model, these rodent models can be used succesfully to screen novel or approved drugs for efficacy to treat human AA. As the pathogenesis of AA follows the canonical lymphocytic co\u2010stimulatory cascade in the mouse AA model, it can be used to screen compounds potentially useful to treat a variety of cell\u2010mediated diseases. Efficacy of various agents can easily be screened by simply observing the presence, rate, and cosmetic acceptability of hair regrowth. More sophisticated assays can refine how the drugs induce hair regrowth and evaluate the underlying pathogenesis of AA. Some drugs commonly used to treat human AA patients work equally as well in both rodent models validating their usefulness as models for drug efficacy and safety for humanAA.\n                  <\/jats:p>","DOI":"10.1111\/j.1600-0625.2008.00773.x","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T04:50:33Z","timestamp":1221108633000},"page":"793-805","source":"Crossref","is-referenced-by-count":59,"title":["The C3H\/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results"],"prefix":"10.1111","volume":"17","author":[{"given":"Jing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"McElwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd E.","family":"King Jr.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Sundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,11]]},"reference":[{"key":"e_1_2_12_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/511442"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsp.5640211"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.4065\/70.7.628"},{"key":"e_1_2_12_5_2","first-page":"386","article-title":"Case of area Celsi (porrigo decalvans) in which the parts were examined after death","volume":"33","author":"Duckworth D","year":"1882","journal-title":"Trans Pathol Soc"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.1017\/S146239940601101X"},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12382416"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000028002"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsp.5640213"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01075.x"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1996.d01-737.x"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1997.tb03777.x"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00380.x"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12164.x"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1087-0024.2003.00806.x"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1995.51"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.23222.x"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01811.x"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.061249"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70342-6"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70238-O"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70017-6"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02505825"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-5-6"},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1996.d01-1044.x"},{"key":"e_1_2_12_26_2","first-page":"1063","article-title":"Predictive model for immunotherapy of alopecia areata with diphencyprone","volume":"137","author":"Wiseman M C","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_12_27_2","first-page":"397","article-title":"Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA)","volume":"35","author":"Galadari I","year":"2003","journal-title":"Allerg Immunol (Paris)"},{"key":"e_1_2_12_28_2","first-page":"333","article-title":"Topical sensitizers in alopecia areata","volume":"16","author":"McMichael A J","year":"2004","journal-title":"Dermatol Nurs"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00416931"},{"key":"e_1_2_12_30_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2340\/00015555761720","article-title":"Growth factor mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone","volume":"76","author":"Hoffmann R","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70400-9"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00640.x"},{"key":"e_1_2_12_33_2","first-page":"443","article-title":"Normalisation of hair follicle morphology in C3H\/HeJ alopecia areata mice after treatment with squaric acid dibutylester","volume":"10","author":"Gardner S","year":"2000","journal-title":"Eur J Dermatol"},{"key":"e_1_2_12_34_2","first-page":"3","article-title":"DPCP for the treatment of alopecia areata","volume":"5","author":"Bolduc C","year":"2000","journal-title":"Skin Therapy Lett"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017935"},{"key":"e_1_2_12_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247540"},{"key":"e_1_2_12_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)02141-8"},{"key":"e_1_2_12_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsp.5640219"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(91)90169-B"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12696879"},{"key":"e_1_2_12_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1984.tb05705.x"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(86)80189-X"},{"key":"e_1_2_12_43_2","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.4049\/jimmunol.143.5.1560","article-title":"On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo","volume":"143","author":"McKinney E C","year":"1989","journal-title":"J Immunol"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.171.4.1315"},{"key":"e_1_2_12_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(93)90060-F"},{"key":"e_1_2_12_46_2","first-page":"563","article-title":"Differential stimulation of immune function by respiratory and contact chemical allergens","volume":"72","author":"Dearman R J","year":"1991","journal-title":"Immunology"},{"key":"e_1_2_12_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(80)90018-4"},{"key":"e_1_2_12_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200105)31:5<1582::AID-IMMU1582>3.0.CO;2-M"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2000.00097-14.x"},{"key":"e_1_2_12_50_2","first-page":"107","article-title":"Oral administration of cyclosporin A in patients with severe alopecia areata","volume":"27","author":"Rallis E","year":"2005","journal-title":"Int J Tissue React"},{"key":"e_1_2_12_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70032-D"},{"key":"e_1_2_12_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12392542"},{"key":"e_1_2_12_53_2","first-page":"684","article-title":"Cyclosporin A stimulates hair growth in nude mice","volume":"56","author":"Sawada M","year":"1987","journal-title":"Lab Invest"},{"key":"e_1_2_12_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(94)90035-3"},{"key":"e_1_2_12_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.11.047"},{"key":"e_1_2_12_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1995.tb02669.x"},{"key":"e_1_2_12_57_2","first-page":"405","article-title":"Treatment of alopecia areata in C3H\/HeJ mice with the topical immunosuppressant FK506 (tacrolimus)","volume":"11","author":"Freyschmidt\u2010Paul P","year":"2001","journal-title":"Eur J Dermatol"},{"key":"e_1_2_12_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.05.019"},{"key":"e_1_2_12_59_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12178.x"},{"key":"e_1_2_12_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(96)00732-0"},{"key":"e_1_2_12_61_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.d01-1232.x"},{"key":"e_1_2_12_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12289702"},{"key":"e_1_2_12_63_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1996.d01-1099.x"},{"key":"e_1_2_12_64_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1087-0024.2003.00812.x"},{"key":"e_1_2_12_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1997.tb03060.x"},{"key":"e_1_2_12_66_2","first-page":"674","article-title":"Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs","volume":"71","author":"Kubeyinje E P","year":"1994","journal-title":"East Afr Med J"},{"key":"e_1_2_12_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1971.tb07230.x"},{"key":"e_1_2_12_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1973.tb06672.x"},{"key":"e_1_2_12_69_2","first-page":"541","article-title":"Is alopecia areata an autoimmune response against melanogenesis\u2010related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?","volume":"66","author":"Paus R","year":"1993","journal-title":"Yale J Biol Med"},{"key":"e_1_2_12_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.23580.x"},{"key":"e_1_2_12_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jeas.2006.10.005"},{"key":"e_1_2_12_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700704"},{"key":"e_1_2_12_73_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00302.x"},{"key":"e_1_2_12_74_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199706)171:3<305::AID-JCP9>3.0.CO;2-S"},{"key":"e_1_2_12_75_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00113.x"},{"key":"e_1_2_12_76_2","first-page":"282","article-title":"Treatment of advanced Hodgkin\u2019s lymphoma: standard and experimental approaches","volume":"36","author":"Engert A","year":"1999","journal-title":"Semin Hematol"},{"key":"e_1_2_12_77_2","doi-asserted-by":"publisher","DOI":"10.1159\/000055305"},{"key":"e_1_2_12_78_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.11.1349"},{"key":"e_1_2_12_79_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.82.6.483"},{"key":"e_1_2_12_80_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0773.2000.860404.x"},{"key":"e_1_2_12_81_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12059.x"},{"key":"e_1_2_12_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(73)90268-3"},{"key":"e_1_2_12_83_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.1975.03260030039018","article-title":"Severe hypertension. Treatment with minoxidil","volume":"233","author":"Mehta P K","year":"1975","journal-title":"JAMA"},{"key":"e_1_2_12_84_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198012183032516"},{"key":"e_1_2_12_85_2","doi-asserted-by":"publisher","DOI":"10.4324\/9780203428528"},{"key":"e_1_2_12_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70084-X"},{"key":"e_1_2_12_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.09.005"},{"key":"e_1_2_12_88_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb09547.x"},{"key":"e_1_2_12_89_2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4049\/jimmunol.158.1.446","article-title":"Effect of estradiol on cytokine secretion by proteolipid protein\u2010specific T cell clones isolated from multiple sclerosis patients and normal control subjects","volume":"158","author":"Gilmore W","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_12_90_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0625.2001.100605.x"},{"key":"e_1_2_12_91_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0625.2003.120104.x"},{"key":"e_1_2_12_92_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2000.278.2.E202"},{"key":"e_1_2_12_93_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.22.12525"},{"key":"e_1_2_12_94_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00257.x"},{"key":"e_1_2_12_95_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1600-0625.2006.00003.x","article-title":"Immunoreactivity of corticotropin\u2010releasing hormone, adrenocorticotropic hormone and alpha\u2010melanocyte\u2010stimulating hormone in alopecia areata","volume":"15","author":"Kim H S","year":"2006","journal-title":"Exp Dermatol"},{"key":"e_1_2_12_96_2","doi-asserted-by":"publisher","DOI":"10.1159\/000249708"},{"key":"e_1_2_12_97_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1963.01590210048007"},{"key":"e_1_2_12_98_2","doi-asserted-by":"publisher","DOI":"10.3109\/9780203490884-44"},{"key":"e_1_2_12_99_2","first-page":"3","volume-title":"Mouse Models of Human Cancer","author":"Boggess D","year":"2004"},{"key":"e_1_2_12_100_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1991.tb06054.x"},{"key":"e_1_2_12_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)70152-6"},{"key":"e_1_2_12_102_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI551"},{"key":"e_1_2_12_103_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsp.5640212"},{"key":"e_1_2_12_104_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.3.1151"},{"key":"e_1_2_12_105_2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4049\/jimmunol.160.3.1212","article-title":"CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells","volume":"160","author":"Suri\u2010Payer E","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_12_106_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01745.x"},{"key":"e_1_2_12_107_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23692.x"},{"key":"e_1_2_12_108_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12335848"},{"key":"e_1_2_12_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12858178"},{"key":"e_1_2_12_110_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1087-0024.2003.00815.x"},{"key":"e_1_2_12_111_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612013398266"},{"key":"e_1_2_12_112_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0906-6705.2004.00098.x"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0625.2008.00773.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0625.2008.00773.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T07:49:23Z","timestamp":1697356163000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0625.2008.00773.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,11]]},"references-count":111,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1600-0625.2008.00773.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0625.2008.00773.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,11]]}}}